Reports for HIKMA CANADA LIMITED

Company Name
HIKMA CANADA LIMITED

Shortage reports

Actual shortage:

20 (19%)

Anticipated shortage:

0 (0%)

Avoided shortage:

1 (1%)

Resolved:

83 (80%)

104

Discontinuation Reports

To be discontinued:

3 (33%)

Discontinued:

6 (67%)

Reversed:

0 (0%)

9

16 (14%)

17 (74%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TESTOSTERONE ENANTHATE INJECTION, USP 200MG SOLUTION Resolved 2024-09-26 2024-12-13 238542
TESTOSTERONE ENANTHATE INJECTION, USP 200MG SOLUTION Resolved 2025-02-04 2025-03-25 249532
TESTOSTERONE ENANTHATE INJECTION, USP 200MG SOLUTION Actual shortage 2025-04-25 2025-04-26 255771
THIOTEPA FOR INJECTION, BP 15MG POWDER FOR SOLUTION Resolved 2024-09-26 2024-11-22 238545

Showing 101 to 104 of 104

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2% SOLUTION Discontinued 2025-03-24 2025-04-07 253339
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2% SOLUTION Discontinued 2025-03-24 2025-04-02 253342
DORZOLAMIDE AND TIMOLOL EYE DROPS BP 5MG 20MG SOLUTION Discontinued 2024-11-01 2025-10-08 241852
LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION 5MG 50MCG SOLUTION Discontinued 2024-10-01 2024-10-02 239073
LATANOPROST OPHTHALMIC SOLUTION 50MCG SOLUTION Discontinued 2025-03-24 2025-04-02 253336
LIDOCAINE HYDROCHLORIDE INJECTION USP 10MG SOLUTION Discontinued 2024-04-19 2024-04-22 225805
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165188
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.375G 3G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165193
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.5G 4G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165196

Showing 1 to 9 of 9